CWIEX
Price
$74.26
Change
-$0.68 (-0.91%)
Updated
Nov 18 closing price
Net Assets
139.93B
TQGIX
Price
$21.01
Change
-$0.18 (-0.85%)
Updated
Nov 18 closing price
Net Assets
125.67M
Interact to see
Advertisement

CWIEX vs TQGIX

Header iconCWIEX vs TQGIX Comparison
Open Charts CWIEX vs TQGIXBanner chart's image
American Funds Capital World Gr&Inc 529E
Price$74.26
Change-$0.68 (-0.91%)
VolumeN/A
Net Assets139.93B
T. Rowe Price Integrated Global Eq I
Price$21.01
Change-$0.18 (-0.85%)
VolumeN/A
Net Assets125.67M
CWIEX vs TQGIX Comparison Chart in %
View a ticker or compare two or three
VS
CWIEX vs. TQGIX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWIEX is a Hold and TQGIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWIEX has more cash in the bank: 140B vs. TQGIX (126M). TQGIX (1.17) and CWIEX (1.15) have matching dividends . CWIEX was incepted earlier than TQGIX: CWIEX (24 years) vs TQGIX (10 years). TQGIX (1.30) is less costly to investors than CWIEX (1.00). TQGIX is a more actively managed with annual turnover of: 48.50 vs. CWIEX (27.00). CWIEX has a lower initial minimum investment than TQGIX: CWIEX (250) vs TQGIX (500000). TQGIX annual gain was more profitable for investors over the last year : 13.15 vs. CWIEX (11.86). TQGIX (43.69) and CWIEX (42.92) have equivalent 5 years return.
CWIEXTQGIXCWIEX / TQGIX
Total Expense Ratio1.000.58172%
Annual Report Gross Expense Ratio1.001.3077%
Fund Existence24 years10 years-
Gain YTD18.59117.440107%
Front LoadN/AN/A-
Min. Initial Investment2505000000%
Min. Initial Investment IRAN/AN/A-
Net Assets140B126M111,111%
Annual Yield % from dividends1.151.1799%
Returns for 1 year11.8613.1590%
Returns for 3 years50.4137.59134%
Returns for 5 years42.9243.6998%
Returns for 10 years91.62N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ECSMX10.12N/A
N/A
Eaton Vance Small-Cap C
EEMHX10.16N/A
N/A
MFS Emerging Markets Equity Research R6
LKEQX40.00N/A
N/A
LKCM Equity
PJHRX36.34N/A
N/A
PGIM Jennison Health Sciences R
HRAUX80.32N/A
N/A
Carillon Eagle Mid Cap Growth R6